Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- ALR Technologies Receives Notice From US Patent Office That Patent Protection Covering Several of Their Products Has Been Allowed
- ALR Technologies Inc. (OTC BB: ALRT), headquartered in Winston-Salem, NC, announced today it has been notified by the US Patent and Trademark Office that patent protection covering important elements of many of their disease management reminder products has been allowed and will soon issue.
- Research articles 2005-02-10
- EnXnet Inc. granted patent protection for EnXcase
- EnXnet Inc. has been granted full patent protection for the EnXcase, a self-contained theft prevention CD/DVD case holder.
- Research articles 2006-10-06
- Schering-Plough Seeks Claritin Extension.
- Drug maker wants three more years of patent protection; opponents cry monopoly. SCHERING-PLOUGH Corporation is defending its push for additional patent protection for its drug Claritin. The company says the success of the allergy medicine has Drug maker...
- Research articles 1999-07-12
- US Drug Industry Wary of Efforts to Weaken Patents
- AN INTERNATIONAL EFFORT to make pharmaceuticals more widely available in developing countries is raising concern in the US drug industry that protection for its valuable patents could be in jeopardy. The World Health Organization WHO WHO is co AN INTERNATIONAL EFFORT to make...
- Research articles 1998-05-18
- eFoodSafety.com Inc. Subsidiary Knock-Out Technologies Ltd. Files for Patent Protection on Bird Flu Formulas; Citroxin and Citroxin O2 Secure 'Patent Pending' Status for Formulations
- SCOTTSDALE, Ariz. -- Patricia Gruden, president/CEO of eFoodSafety.com Inc. (OTCBB: EFSF), announced today that the company's wholly owned subsidiary, Knock-Out Technologies Ltd., has filed with the United States Patent and Trademark Office for patent protection on their bird flu formulations, Citroxin and Citroxin O2.
- Research articles 2006-04-19
- US Drug Industry Wary of Efforts to Weaken Patents.(US drug industry worried its patents could be put in jeopardy by global effort to make pharmaceuticals more widely available in developing countries)
- AN INTERNATIONAL EFFORT to make pharmaceuticals more widely available in developing countries is raising concern in the US drug industry that protection for its valuable patents could be in jeopardy. The World Health Organization WHO WHO is co AN INTERNATIONAL EFFORT to make...
- Research articles 1998-05-18
- Patriot Scientific Receives Patent Protection For Antenna Technology
- SAN DIEGO--BUSINESS WIRE--Nov. 5, 1997--
- Research articles 1997-11-05
- SRS Labs Announces Patent Protection of SRS WOW® Now Covers United States, Europe and China; With Newly Granted US and Chinese Patents, SRS Labs Customers Now Enjoy Broad Patent Protection for Popular 3D Audio Enhancement Technique
- SANTA ANA, Calif. -- SRS Labs Inc. (NASDAQ:SRSL), a leading provider of surround sound, audio and voice technologies, was recently awarded U.S. Patent 7,031,474, entitled "Acoustic correction apparatus," to cover its award-winning SRS WOWR audio enhancement technology. Specifically, the patent covers methods of acoustic compensation for spatial and spectral distortion...
- Research articles 2006-08-02
- Scan-Optics Files for Patent Protection for SO Series Scanner
- MANCHESTER, Conn. -- Scan-Optics, Inc. (OTC BB: SOCR), a leader in information capture and customer service solutions for government, insurance, order fulfillment, proxy, health claims, test scoring and other paper-intensive businesses, today announced that it has filed a provisional application for patent protection covering the novel features of its recently...
- Research articles 2004-12-01
- Salix Pharmaceuticals Acquires Patent-Protected, Liquid Peg Bowel Cleanser from Norgine; FDA Review Response Due April 2006
- RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Norgine B.V. has granted Salix the exclusive rights to sell a patent-protected, liquid PEG bowel cleansing product, NRL944, in the United States. The product is currently under review at the U.S. Food and Drug Administration FDA to obtain marketing approval...
- Research articles 2005-12-07
- Hot Stocks to Watch for Friday, April 28, 2006: Patent Protection for Core Drug Discovery and Toxicology Platform!
- TheSUBWAY.com announces the following stocks to its Hot Stocks List: Stem Cell Innovations, Inc. (OTC BB: SCLL), Conexant Systems, Inc. (NASDAQ: CNXT), Intuitive Surgical, Inc. (NASDAQ: ISRG), Nektar Therapeutics (NASDAQ: NKTR).
- Research articles 2006-04-28
- EnXnet, Inc. Expands World Wide Patent Protection to Non-PCT Member, Argentina, for Thindisc Technology
- TULSA, Okla. -- EnXnet, Inc. (OTCBB:EXNT)(German WKN# AOHMDW) announces it has filed for Patent rights with the Argentinean Patent Office for its ThinDisctm patent filed in March 2005 with the United States Patent Office and internationally under the PCT Patent Cooperation Treaty in February 2006.
- Research articles 2006-03-08
- Ecopia Obtains Patent Protection on ECO-4601 from the USPTO
- MONTREAL -- Ecopia BioSciences Inc. (TSX:EIA) is pleased to announce it has received a Notice of Allowance from the United States Patent and Trade-mark Office ("USPTO") for a patent application directed to ECO-4601, the Company's lead anticancer compound that is in preparation for its Phase I clinical trials. The allowed...
- Research articles 2005-12-07
- World Trade Organization Denies Canada's Appeal for Shorter Patent Protection.
- MONTREAL, Sep 19, 2000 MONTREAL, Sep 19, 2000
- Research articles 2000-09-19
- TheSUBWAY.com Posts Stock Pick List: Filing for Patent Protection!
- TheSUBWAY.com names the following stocks to its Stock Pick List: eWAN1, Inc. (OTC: EWAN), Juniper Networks, Inc. (NASDAQ: JNPR), JDS Uniphase (NASDAQ: JDSU), CIENA Corporation (NASDAQ: CIEN).
- Research articles 2006-04-19
- Amgen obtains broader patent protection for NEUPOGEN
- THOUSAND OAKS, Calif.--BUSINESS WIRE--Dec. 4, 1996--Amgen (NASDAQ:AMGN) Wednesday announced that the U.S. Patent and Trademark Office has issued to the company a patent covering product rights to its recombinant G-CSF or NEUPOGEN R Filgrastim.
- Research articles 1996-12-04
- Administration proposes pro-generics rule changes.(White House proposes to block brand-name drug companies from filing multiple patent-protection lawsuits)
- THE WHITE HOUSE proposed new regulations last week that would make it easier for generic drugs to reach the market by blocking brand-name pharmaceutical companies from filing multiple patent-protection lawsuits. "I'm taking action to clo THE WHITE HOUSE...
- Research articles 2002-10-28
- KODAK WILL APPEAL VERDICT IN 'ISO' CASE Kodak Contends Verdict Usurps Patent Protection
- ROCHESTER, N.Y.--BUSINESS WIRE--Sept. 19, 1995--Eastman Kodak Company today said it would appeal yesterday's jury verdict finding that it violated the antitrust laws by refusing to sell photocopier and micrographics parts to competing service providers.
- Research articles 1995-09-19
- Dyax Corp. Expands Patent Protection for DX-88 in On-Pump Cardiothoracic Surgery
- CAMBRIDGE, Mass. -- Dyax Corp. (NASDAQ: DYAX) announced today the issuance of a U.S. patent for its lead product candidate DX-88, a non-naturally occurring kallikrein inhibitor, and its uses. U.S. Patent No. 7,235,530 (issued June 26, 2007), relates to the company's DX-88 program in on-pump cardiothoracic surgery CTS, and provides...
- Research articles 2007-07-19
- Patentable Subject [Anti] Matter
- In general, man-made inventions and new compositions of matter are proper subjects of patent protection, while products of nature are not. The lawmakers in the United States are in dilemma. The cause for this dilemma stems from the fact that antihydrogen, a newly created element made entirely of antimatter, has...
- White papers 2003-01-01
- << Previous
- page 1 of 2
- Next >>
